Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Total 13F shares
-
33,367,517
-
Share change
-
-1,696,162
-
Total reported value
-
$85,752,736
-
Put/Call ratio
-
62%
-
Price per share
-
$2.57
-
Number of holders
-
73
-
Value change
-
-$4,279,425
-
Number of buys
-
33
-
Number of sells
-
33
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q3 2022
As of 30 Sep 2022,
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,367,517 shares.
The largest 10 holders included
Redmile Group, LLC, Frazier Life Sciences Management, L.P., Versant Venture Management, LLC, VANGUARD GROUP INC, Palo Alto Investors LP, MORGAN STANLEY, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, Assenagon Asset Management S.A., and Artal Group S.A..
This page lists
73
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.